NCT05476406

Brief Summary

The purpose of the study was to evaluate the effectiveness of the äKwä 6-step skincare system by measuring skin moisture level, fine lines and wrinkles, porphyrin count, red spots, and red vasculature counts over a 30-day period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 11, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 26, 2019

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

July 12, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

July 27, 2022

Completed
Last Updated

July 27, 2022

Status Verified

July 1, 2022

Enrollment Period

2 months

First QC Date

July 12, 2022

Last Update Submit

July 25, 2022

Conditions

Outcome Measures

Primary Outcomes (7)

  • Skin Hydration

    measure facial skin moisture level at pre-defined spots, with SkinFit instrument

    30 days

  • Red Spot Count

    measure the number of facial red spots at predefined areas, with SkinFit instrument

    30 days

  • Red Vascular Count

    measure the number of facial red vasculature at predefined areas, with SkinFit instrument

    30 days

  • Porphyrin Count

    measure the number of facial porphyrin at predefined areas, with SkinFit instrument

    30 days

  • Wrinkles

    measure the number of wrinkles and fine lines at predefined areas, with SkinFit instrument

    30 days

  • Pores

    measure the number of skin pores at predefined areas, with SkinFit instrument

    30 days

  • Texture

    measure the number of uneven skin textures, at predefined areas, with SkinFit instrument

    30 days

Study Arms (2)

äKwä Group

EXPERIMENTAL

participants use äKwä products daily as instructed for 30 days

Other: äKwä skincare system products

Control Group

ACTIVE COMPARATOR

participants use a competitor products daily as instructed for 30 days

Other: competitor products (control)

Interventions

The skincare product system tested in this study was äKwä 6-step skincare system from 4Life Research USA, LLC ( https://www.4life.com/6613461/page/äKwä). Product directions state to use the following products morning and night in sequential order: First Wave Oil-to-Foam Cleanser, Glacier Glow Four-Way Toner, Precious Pool Vitamin Essence, Ripple Refine Eye Cream, and RainBurst Moisture Cream.

äKwä Group

Participants use whatever their normal daily routine of skincare products, which are commercially available competitor products from the marketplace.

Control Group

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Individuals could participate who were at least 18 years old and in good health.

You may not qualify if:

  • had allergies or contraindications to any ingredient of products,
  • had a history of any acute or chronic disease that could interfere with or increase the risk of study participation
  • had any medical procedures, such as laser resurfacing, or plastic surgery to the test sites within the last 12 months (including Botox, Restylyn, or other fillers)
  • chronic skin allergies (dermatitis, eczema, psoriasis)
  • had been treated for skin cancer within the last 12 months or have damaged skin near the facial area (e.g., sunburn, tattoos, scars, or other disfigurations)
  • pregnant or planning to become pregnant in the following 12 weeks, or lactating

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

4Life Research

Sandy City, Utah, 84070, United States

Location

Study Officials

  • David Vollmer, PhD

    4LIFE

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: One Active group and one Control group
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2022

First Posted

July 27, 2022

Study Start

April 11, 2019

Primary Completion

May 30, 2019

Study Completion

July 26, 2019

Last Updated

July 27, 2022

Record last verified: 2022-07

Locations